Serra-Navarro M., Amoretti S., Verdolini N., Forte M.F., Sánchez-Torres A.M., Vieta E., Clougher D., Lobo A., González-Pinto A., Panadero R., Roldán A., Carvalho A.F., de la Serna E., Toll A., Ramos-Quiroga J.A., Torrent C., Cuesta M.J., Bernardo M., PEPs Grp. Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: differences between males and females (vol 13, 982583, 2022). Frontiers in Psychiatry. 2023; 14DOI:10.3389/fpsyt.2023.1200313. PMID:37383614. IF:3.200(Q2/4D).

Pascual, JC, Arias, L, Soler, J. Pharmacological Management of Borderline Personality Disorder and Common Comorbidities. CNS DRUGS. 2023; 37(6)DOI:10.1007/s40263-023-01015-6. PMID:37256484. IF:7.400(Q1/1D).

Fraguas D., Almenta Gallego D., Arques-Egea S., Gómez-Revuelta M., Sánchez-Lafuente C.G., Hernández Huerta D., Núñez Arias D., Oda Plasencia-García B., Parro Torres C., Romero-Guillena S.L., Ros Cucurul E., Alamo C.. Aripiprazole for the treatment of schizophrenia: Recommendations of a panel of Spanish experts on its use in clinical practice. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE. 2023; 27(1)DOI:10.1080/13651501.2022.2064308. PMID:35792729. IF:2.900(Q2/4D).

Valli, I, Segura, AG, Verdolini, N, Garcia-Rizo, C, Berge, D, Baeza, I, Cuesta, MJ, Gonzalez-Pinto, A, Lobo, A, Martinez-Aran, A, Mezquida, G, Pina-Camacho, L, Bejarano, AR, Mas, S, McGuire, P, Bernardo, M, Vieta, E, PEPs Grp. Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis. ACTA PSYCHIATRICA SCANDINAVICA. 2023; 148(1)DOI:10.1111/acps.13546. PMID:36912272. IF:5.300(Q1/2D).